---
category: news
title: "Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company"
abstract: "His discoveries, including the DIAMOND AI artificial intelligence algorithms ... that have been proven safe and effective for eliciting immune responses for cancer therapy. The future is bright for advancing immunotherapy as the new standard of care ..."
publishedDateTime: 2019-06-27T06:59:00Z
sourceUrl: https://www.bakersfield.com/ap/news/generex-signs-letter-of-intent-with-kiromic-to-merge-with/article_04ab5610-5319-5068-9f68-38a96dbca8f9.html
type: article

provider:
  name: The Bakersfield Californian
  id: thebakersfieldcalifornian

topics:
 - AI
 - artificial intelligence therapy
 - AI in Healthcare

images:
  - url: https://bloximages.newyork1.vip.townnews.com/bakersfield.com/content/tncms/custom/image/d09180fc-6bee-11e7-8b72-ff928e2e17d5.png
    width: 1200
    height: 630
    title: "Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company"
---
